Bell Investment Advisors, Inc Qiagen N.V. Transaction History

Bell Investment Advisors, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$35.55 - $43.57 $177 - $217	5 Added 7.14%	75 $3,000
Q3 2023 Nov 08, 2023	SELL	$39.13 - $47.24 $2,934 - $3,543	-75 Reduced 51.72%	70 $2,000
Q2 2023 Aug 09, 2023	SELL	$43.93 - $46.76 $1,010 - $1,075	-23 Reduced 13.69%	145 $6,000
Q1 2023 May 10, 2023	SELL	$45.29 - $50.76 $679 - $761	-15 Reduced 8.2%	168 $7,000
Q4 2022 Feb 08, 2023	BUY	$41.91 - $50.48 $2,849 - $3,432	68 Added 59.13%	183 $9,000

Q3 2022 Nov 09, 2022	SELL	$40.9 - $50.42 $449 - $554	-11 Reduced 8.73%	115 $5,000
Q2 2022 Aug 12, 2022	BUY	$42.98 - $49.77 $3,610 - $4,180	84 Added 200.0%	126 $6,000
Q4 2021 Feb 14, 2022	SELL	$50.62 - $56.47 $2,176 - $2,428	-43 Reduced 50.59%	42 $2,000
Q3 2021 Nov 12, 2021	BUY	$46.55 - $56.83 $3,956 - $4,830	85 New	85 $4,000

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bell Investment Advisors, Inc with notifications on news.